Company news
Talphera, Inc. news in 2024
Talphera, Inc.'s news releases, calls and decks from 2024, newest first.
Ascentage Pharma Appoints Ms. Marina S. Bozilenko and Dr. Debra Yu as Independent Non-Executive Directors
November 23, 2024
Talphera Announces Third Quarter 2024 Financial Results and Provides Corporate Update
November 12, 2024
Talphera to Host Third Quarter 2024 Financial Results and Corporate Update Call and Webcast on Wednesday, November 13, 2024
November 5, 2024
Talphera to Participate in Fireside Chat at the 2024 Maxim Healthcare Virtual Summit
October 7, 2024
Talphera to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
September 4, 2024
Talphera Announces First Patient Enrolled in the Registrational Trial Evaluating Nafamostat for Anticoagulation of the Extracorporeal Circuit
August 18, 2024
Talphera Announces Second Quarter 2024 Financial Results and Provides Corporate Update
August 13, 2024
Talphera to Host Second Quarter 2024 Financial Results and Corporate Update Call and Webcast on Wednesday, August 14, 2024
August 4, 2024
Talphera Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
May 19, 2024
Talphera to Participate at A.G.P. Virtual Healthcare Conference
May 15, 2024
Talphera Announces First Quarter 2024 Financial Results and Provides Corporate Update
May 13, 2024
Talphera to Host First Quarter 2024 Financial Results Call and Webcast on Tuesday, May 14, 2024
May 1, 2024
Talphera Announces Fourth Quarter 2023 Financial Results and Provides Corporate Update
March 5, 2024
Talphera Announces Reduction in Size of its Board of Directors from Ten to Seven Members
February 29, 2024
Talphera to Host Fourth Quarter and Full-Year 2023 Financial Results Call and Webcast on March 6, 2024
February 25, 2024
Talphera Announces $26 Million Capital Commitment Through a Combination of a Non-Dilutive Royalty Monetization and Equity Offering
January 17, 2024